Imiquimod for Treatment of External Genital Warts
Links shared publicly online about this topic
FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
drugs.com — “Zyclara (imiquimod) is used to treat external genital and perianal warts. Includes Zyclara side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 27, 2011 at 9:05 pm By:
FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts - http://bit.ly/hqMrNr
FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
drugs.com — “Zyclara (imiquimod) is used to treat external genital and perianal warts. Includes Zyclara side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 27, 2011 at 9:10 pm By:
Drugs and Devices OW OW Health
FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts: BRISTOL, Tenn.-... http://bit.ly/h1FQaV #drug
Health Canada Approves PrVylomaTM (Imiquimod) Cream 3.75% For The Treatment Of External Genital Warts
medicalnewstoday.com — “Graceway Pharmaceuticals Canada announced that Health Canada has approved Vyloma[i] (imiquimod) Cream 3.75%, a topical prescription for the treatment of external genital warts (EGW) and perianal w” View full resource at medicalnewstoday.com
Most Recently Shared on March 24, 2011 at 12:05 pm By:
Health Canada Approves PrVylomaTM (Imiquimod) Cream 3.75% For The Treatment Of External Genital Warts http://mnt.to/3SGP #sexualhealth
FDA Approves Zyclara(R) (Imiquimod) Cream, 3.75% For The Treatment Of External Genital Warts
medicalnewstoday.com — “Graceway® Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved Zyclara® Cream for the treatment of external genital and perianal warts (EGW) in patients 12 ye” View full resource at medicalnewstoday.com
Most Recently Shared on March 28, 2011 at 10:05 am By:
FDA Approves Zyclara(R) (Imiquimod) Cream, 3.75% For The Treatment Of External Genital Warts http://mnt.to/3SNC #sexualhealth
Zyclara Approved for Treating External Genital Warts - MPR
empr.com — “Zyclara (imiquimod cream, Graceway Pharmaceuticals) has been approved for the treatment of external genital and perianal warts in patients 12 years of age.” View full resource at empr.com
Most Recently Shared on March 25, 2011 at 2:59 pm By:
MPR News: Zyclara Approved for Treating External Genital Warts: Zyclara (imiquimod cream, Graceway Pharmaceutica... http://bit.ly/f3cKR2
Zyclara Approved for Treating External Genital Warts - ONA
oncologynurseadvisor.com — “Zyclara (imiquimod cream, Graceway Pharmaceuticals) has been approved for the treatment of external genital and perianal warts in patients 12 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 25, 2011 at 3:07 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Zyclara Approved for Treating External Genital Warts http://goo.gl/fb/t2rZR
New Data Demonstrate Zyclara™ Imiquimod 3.75% Superior To Placebo For Treatment Of External Genital Warts (EGW)
medicalnewstoday.com — “Results from a Phase III program evaluating imiquimod 3.75% and 2.5% creams for the treatment of EGW, applied once daily for up to 8 weeks, demonstrated that both were well-tolerated and more effi” View full resource at medicalnewstoday.com
Most Recently Shared on July 13, 2010 at 11:52 am By:
New Data Demonstrate Zyclara Imiquimod 3.75% Superior To Placebo For Treatment Of External Genital Warts (EGW): Re... http://mnt.to/f/3FZ5
Internal Genital Warts
treatmentforgenitalwarts.info — “Internal Genital Warts” View full resource at treatmentforgenitalwarts.info
Most Recently Shared on August 12, 2010 at 11:33 pm By:
Internal genital warts are caused by the same virus that results in external genital warts. Learn about treatment. http://bit.ly/dqfpOn
CDC Recommends VEREGEN® as Therapeutic Option for External Genital Warts in the 2010 Sexually Transmitted Diseases Treatment Guidelines - Health News - redOrbit
redorbit.com — “FLORHAM PARK, N.J., Jan.” View full resource at redorbit.com
Most Recently Shared on January 6, 2011 at 7:32 am By:
OrganizedWisdom STDs OW Health
CDC Recommends VEREGEN® as Therapeutic Option for External Genital Warts in the 2010 Sexually Transmitted Diseas... http://bit.ly/ehJYzL
Perrigo Announces FDA Approval For Imiquimod Cream Generic Equivalent To Aldara®
medicalnewstoday.com — “Perrigo Company (Nasdaq: PRGO;TASE) announced it received FDA approval from the U.S. Food and Drug Administration to manufacture and market Imiquimod Cream, 5%. Perrigo will vertically integrate t” View full resource at medicalnewstoday.com
Most Recently Shared on September 14, 2010 at 1:26 pm By:
Perrigo Announces FDA Approval For Imiquimod Cream Generic Equivalent To Aldara®: Perrigo Company (Nasdaq: PRGO;TA... http://mnt.to/f/3JH4
VEREGEN Ointment added as new therapeutic option in 2010 CDC STD Treatment Guidelines
news-medical.net — “PharmaDerm, a division of Nycomed US Inc., announced today that VEREGEN (sinecatechins) Ointment, 15%, a topical medication for the treatment of external genital and perianal warts, has been added as a new therapeutic option in the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.” View full resource at news-medical.net
Most Recently Shared on January 6, 2011 at 1:33 pm By:
OrganizedWisdom STDs OW Health
VEREGEN Ointment added as new therapeutic option in 2010 CDC STD Treatment Guidelines: PharmaDerm, a division of... http://bit.ly/g0nwJS
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Sexual Health
The latest sexual health news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
